Dialysis-related amyloidosis
- 1 May 1992
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 41 (5) , 1416-1429
- https://doi.org/10.1038/ki.1992.207
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or, perhaps amyloid is not a misnomerMedical Hypotheses, 1988
- LymphokinesNew England Journal of Medicine, 1987
- HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSISThe Lancet, 1986
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- In vitro formation of amyloid fibrils from intact β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Complement Activation and Hypersensitivity Reactions to Dialysis MembranesNew England Journal of Medicine, 1984
- Hemodialysis Hypotension: The Interleukin HypothesisBlood Purification, 1983
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- Serum β2-Microglobulin in Hemodialyzed PatientsNephron, 1978